📈 Stocks 🌍 United States

InnovAge Reports 175% EBITDA Growth, Launches Strategic Scaling Phase

InnovAge posts robust fiscal 2026 results with a 175% jump in adjusted EBITDA, signaling a shift toward aggressive scaling and value-based care expansion in the coming fiscal year.

📅 September 9, 2026 🕐 1 min read

1 assets impacted. Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: INNV ↑ 7/10 (60% confidence).

📊 Affected Assets (1)

INNV

Bullish 🤖 60%

📅 Short-term 🌍 US · Explicit

InnovAge reported strong fiscal Q4 2026 results with adjusted EBITDA up 175% year over year and a positive outlook for scaling its PACE platform.

🎯 Key Takeaways

Adjusted EBITDA surged 175% year-over-year, driven by improved operational discipline and favorable rate environments.
The company is transitioning to 'InnovAge 3.0,' focusing on scaling its PACE platform and leveraging AI for clinical decision support.
New COO Jen Browne will lead efforts to standardize center-level accountability and enhance the participant experience.

📝 Executive Summary

InnovAge Holding Corp. reported a strong fiscal 2026, highlighted by a 175% year-over-year increase in adjusted EBITDA. CEO Patrick Blair announced the company is entering 'InnovAge 3.0,' a new strategic phase focused on scaling its PACE platform through technology, AI integration, and expanded operational capacity.

❓ FAQ

What is the 'InnovAge 3.0' strategy?

InnovAge 3.0 is the company's new strategic phase focused on scaling its value-based care platform, diversifying growth channels, and utilizing AI and technology to improve clinical outcomes and operational efficiency.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article